Reshma Kewalramani Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Reshma Kewalramani.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Reshma Kewalramani. Reshma Kewalramani is a CEO & President in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and a EVP and CMO in VERTEX PHARMACEUTICALS INC / MA ($VRTX).

Address: C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON 02210 MA

Companies in which Reshma Kewalramani is an Insider

VERTEX PHARMACEUTICALS INC / MA

Trading Symbol: VRTX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Reshma Kewalramani: CEO & President, EVP and CMO
Holdings: 63,643 shares
Current Value: $5,526,758
Latest Transaction: Feb 26 2021
$VRTX Market Capitalization: $21.78B
$VRTX Previous Close: $86.84

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Reshma Kewalramani

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 26 2021VRTXVERTEX PHARMACEUTI ...Kewalramani ReshmaCEO & PresidentPayment of ExerciseF217.572,898630,51863,64366.5 K to 63.6 K (-4.36 %)
Feb 19 2021VRTXVERTEX PHARMACEUTI ...Kewalramani ReshmaCEO & PresidentPayment of ExerciseF211.752,080440,44066,54168.6 K to 66.5 K (-3.03 %)
Feb 05 2021VRTXVERTEX PHARMACEUTI ...Kewalramani ReshmaCEO & PresidentGrantA0.0029,031071,58342.6 K to 71.6 K (+68.22 %)
Feb 05 2021VRTXVERTEX PHARMACEUTI ...Kewalramani ReshmaCEO & PresidentGrantA0.0012,388042,55230.2 K to 42.6 K (+41.07 %)
Feb 05 2021VRTXVERTEX PHARMACEUTI ...Kewalramani ReshmaCEO & PresidentGrantA0.003,516030,16426.6 K to 30.2 K (+13.19 %)
Feb 05 2021VRTXVERTEX PHARMACEUTI ...Kewalramani ReshmaCEO & PresidentGrantA0.0029,031071,58342.6 K to 71.6 K (+68.22 %)
Feb 05 2021VRTXVERTEX PHARMACEUTI ...Kewalramani ReshmaCEO & PresidentGrantA0.0012,388042,55230.2 K to 42.6 K (+41.07 %)

View all Reshma Kewalramani insider transactions.